Kevin Camphausen

Kevin Camphausen is chief of the Radiation Oncology Branch at the National Cancer Institute at the National Institutes of Health. Camphausen studies the interaction of novel drugs and radiotherapy in the treatment of glioblastoma multiforme brain tumors—in the laboratory, using preclinical model systems, and in the clinic, running clinical trials. Camphausen guides the branch’s clinical/translational program, which studies the role of new agents as both radiation sensitizers and radiation protectors. Camphausen is an internationally recognized leader in his field and an expert in drug-induced tumor radiosensitization.